Mortality of Japanese patients with Leigh syndrome: Effects of age at onset and genetic diagnosis
Open Access
- 22 January 2020
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 43 (4) , 819-826
Abstract
Leigh syndrome is a major phenotype of mitochondrial diseases in children. With new therapeutic options being proposed, assessing the mortality and clinical condition of Leigh syndrome patients is crucial for evaluating therapeutics. As data are scarce in Japan, we analysed the mortality rate and clinical condition of Japanese Leigh syndrome patients that we diagnosed since 2007. Data from 166 Japanese patients diagnosed with Leigh syndrome from 2007 to 2017 were reviewed. Patients' present status, method of ventilation and feeding, and degree of disability as of April 2018 was analysed. Overall, 124 (74.7%) were living, 40 (24.1%) were deceased, and 2 (1.2%) were lost to follow‐up. Median age of living patients was 8 years (1‐39 years). Median length of disease course was 91 months for living patients and 23.5 months for deceased patients. Nearly 90% of deaths occurred by age 6. Mortality rate of patients with onset before 6 months of age was significantly higher than that of onset after 6 months. All patients with neonatal onset were either deceased or bedridden. MT‐ATP6 deficiency caused by m.8993T>G mutation and MT‐ND5 deficiency induced a severe form of Leigh syndrome. Patients with NDUFAF6, ECHS1, and SURF1 deficiency had relatively mild symptoms and better survival. The impact of onset age on prognosis varied across the genetic diagnoses. The clinical condition of many patients was poor; however, few did not require mechanical ventilation or tube‐feeding and were not physically dependent. Early disease onset and genetic diagnosis may have prognostic value.Keywords
Funding Information
- Japan Agency for Medical Research and Development (18ek0109177, 19ek0109276, 19ek0109273)
- Takeda Science Foundation
This publication has 21 references indexed in Scilit:
- ECHS1 mutations in Leigh disease: a new inborn error of metabolism affecting valine metabolismBrain, 2014
- A multicenter study on Leigh syndrome: disease course and predictors of survivalOrphanet Journal of Rare Diseases, 2014
- SURF1 deficiency: a multi-centre natural history studyOrphanet Journal of Rare Diseases, 2013
- A guide to diagnosis and treatment of Leigh syndromeJournal of Neurology, Neurosurgery & Psychiatry, 2013
- EPI-743 reverses the progression of the pediatric mitochondrial disease—Genetically defined Leigh SyndromeMolecular Genetics and Metabolism, 2012
- Natural disease course and genotype‐phenotype correlations in Complex I deficiency caused by nuclear gene defects: what we learned from 130 casesJournal of Inherited Metabolic Disease, 2012
- Leigh Syndrome: Clinical and Neuroimaging Follow-UpPediatric Neurology, 2009
- Mutations of SURF-1 in Leigh Disease Associated with Cytochrome c Oxidase DeficiencyThe American Journal of Human Genetics, 1998
- Leigh syndrome: Clinical features and biochemical and DNA abnormalitiesAnnals of Neurology, 1996
- SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY IN AN INFANTJournal of Neurology, Neurosurgery & Psychiatry, 1951